Abstract. In Panama, hantavirus pulmonary syndrome (HPS) is caused by Choclo virus, a species phylogenetically related to Andes and Maporal viruses. Up to 60% of the population has been positive for specific serum antibody in community-based surveys, but mortality is very uncommon. In four western Panama clinics, we tested individuals presenting with a severe febrile prodrome for acute hantavirus (HV) infection by immunoglobulin M enzyme-linked immunosorbent assay and reverse transcription polymerase chain reaction as well as clinically similar infections, such as dengue and leptospirosis. From 2006 to 2009, at least 21% of 117 patients diagnosed with HV infection had HV Fever (HF) with no evidence of pulmonary edema (no respiratory distress or radiographic lung infiltrates), and 44% of patients had very mild HPS (radiographic pulmonary edema but no respiratory insufficiency). HV infection caused by Choclo virus in Panama presents often as HF, which contrasts with HV in the Americas but is consistent with the high seroprevalence in endemic regions.
INTRODUCTION
Hantavirus (HV) infections were first described in the Americas during an outbreak in southwestern United States in 1993 and have since been found throughout North, South, and Central America. 1 The primary manifestation of HV infection is pulmonary edema; thus, HV pulmonary syndrome (HPS) or HV cardiopulmonary syndrome (HCPS) is often a dominant feature when severe pulmonary edema and cardiogenic shock are present. In Panama, Choclo virus was first described in 2000 during an outbreak in the agroecosystems of the Azuero Peninsula in western Panama. 2, 3 Choclo virus is hosted by the fulvous rice rat (Oligoryzomys fulvescens) 2 and displays a peridomestic habitat preference. 4 Choclo virus is phylogenetically related to Maporal virus in Venezuela, Laguna Negra virus in Paraguay, and Andes virus in Argentina and Chile, and it seems to be responsible for almost all human infections in Panama. 4, 5 Three other HVs are found in Panama, including two in the HPS-endemic region (Calabazo virus in Zygodontomys brevicauda cherriei and an unnamed virus in Sigmodon hirsutus) and one outside of the HPS-endemic region (a relative of Rio Segundo virus in Reithrodontomys species). 4, 6 A high prevalence of HV antibodies in serum, ranging from 12% to 45%, was noted in neighborhoods of HPS patients 3 and community-wide surveys 7, 8 among individuals who had no history of hospitalization for respiratory insufficiency. A comparably high seroprevalence found in northern Argentina and Paraguay 9 and in Brazil [10] [11] [12] contrasts with low seroprevalence in Andes virus-endemic regions. 13, 14 In four Panama communities, repeated seroprevalence surveys found that history-negative infections outnumbered hospitalized HPS in the same region by a ratio of 14:1. 8 These observations implied that a large fraction of Choclo virus infections were asymptomatic, did not develop pulmonary edema, or were mild HPS.
To identify mild as well as severe HV infections, we conducted active surveillance at four clinics in the endemic region of Panama for patients with febrile illnesses accompanied by prodromal symptoms typical of HV infection, including myalgias, headache, chills, and nausea. Diagnosis of HV infection was sought by three assays, and pulmonary involvement was assessed by symptoms, pulse oximetry, and chest radiography to identify graded severity of disease.
MATERIALS AND METHODS
Four communities located within HV-endemic agricultural ecosystems in Western Panama were selected for clinic-based patient recruitment. One community in Los Santos Province (Tonosí), two communities in Coclé Province (Aguadulce and Natá), and one community in Veraguas Province (Soná) had 24-hour clinics with onsite diagnostic capabilities for acute infections, an onsite immunoglobulin M (IgM) HV antibody assay, and previous experience in diagnosing at least 10 cases of HPS. Patient recruitment began in May of 2006 and ended in March of 2010. A total of 10,917 patients were seen for febrile illness in these four clinics, including 7,821 children under the age of 15 years.
Informed written consent was obtained from all adult participants, and written assent was obtained from the parents of children. Consent forms were reviewed and approved by institutional ethics review boards at the University of New Mexico and the Gorgas Memorial Institute in Panama City along with the protocol review committee of the International Centers for Infectious Diseases Research program of the National Institute of Allergy and Infectious Diseases. All adults permanently residing in each community, free of known chronic infections, and presenting to the clinic with an acute febrile illness of more than 24-hours duration and symptoms suggesting HV prodrome were eligible for the study. Recruitment targeted patients with two or more prodrome symptoms (myalgia, headache, chills, nausea, and vomiting) and the absence of upper respiratory symptoms to avoid recruitment of the large numbers of influenza and other respiratory infections. Symptoms and physical examination were recorded on a standardized questionnaire form validated in a preliminary study at one site (Tonosí). Surveillance for all HPS was conducted through review of cases reported to the Ministry of Health. The diagnosis of HV infection required either IgM-positive serology by both of two assays or detection of Choclo virus RNA by reverse transcription polymerase chain reaction (RT-PCR) in serum.
Heparinized whole blood from arm venipuncture was separated by centrifugation, and plasma was stored at −20 C until analysis. Antibody to all known HVs indigenous to the Americas was cross-reacted to the N protein of Sin Nombre virus in binding assays. A strip immunoblot assay (SIA) for IgM antibody containing recombinant N protein of the 3H226 genotype of Sin Nombre virus was used as described; the criterion for positivity was a dark band to Sin Nombre N protein at a serum dilution of 1:200. 15 An enzyme immunoassay (EIA; Focus Diagnostics, Cypress, CA) used recombinant nucleocapsid protein from Sin Nombre virus.
14 Using the cutoff value established by the manufacturer, comparison with the Western blot test 13 and the EIA assay of the Centers for Disease Control 16 for 50 HPS subjects in Panama and a panel of healthy blood donor sera found a sensitivity of 100% and a specificity of 97%.
Genomic viral RNA was sought in acute blood from plasma, cell pellet, or both using a Choclo virus-specific RT-PCR assay with the following nested primers: HVF: 5 -AATGTCYTK GATGTKAACTC-3; HVR: 5 -KKCCAGGTGTWATYTCA TCA-3 for first-round PCR (50 C for 30 minutes, 35 cycles at 94 C for 45 seconds and 57 C for 1 minute, 60 cycles at 72 C for 1 minute, and final extension for 5 minutes at 72 C) that amplifies a 317-bp fragment of the S gene. The second-round PCR amplifies a fragment of around 250 bp with HVCHF: 5 -AATGTCTTGGATGTGAACTC-3 ; HVCHR: 5 -AGTGG GCATCGACACATAAA-3 (94 C for 2 minutes, 35 cycles at 94 C for 45 seconds, 60 C for 30 seconds, and 72 C for 30 seconds, and final extension for 5 minutes at 72 C). PCR products were electrophoresed on 2% agarose gels.
This assay does not detect genomic RNA of either Calabazo or Rio Segundo viruses.
Evidence for five other acute infections that clinically mimic HV infection was sought in the clinic. Acute leptospirosis was identified by a specific IgM assay (PanBio, Brisbane, Queensland, Australia) and RT-PCR. 17 Acute malaria was sought by inspection of thick and thin smears of peripheral blood by an experienced technician. Acute mononucleosis was diagnosed by a titer 128 in an IgM assay to EpsteinBarr virus (PanBio, Brisbane, Queensland, Australia) following the manufacturer's instructions. Influenza was sought by indirect immunofluorescent assay of nasal swab specimens. Dengue virus and Rickettsia acute infections were identified by measuring IgM titers by enzyme-linked immunosorbent assay (ELISA) and indirect flourescent antibody (IFA), respectively (Focus Diagnostics Cypress, CA).
A peripheral blood cell count, chest radiography, serum electrolytes with blood urea nitrogen (BUN) and creatinine, liver enzymes, and arterial blood gas analysis were performed at the discretion of the attending physician. All chest radiographs (61 HV+ and 13 HV− subjects) were read by a board-certified radiologist. Arterial blood gases were measured in 65 patients (Instrumentation Laboratory GEM Premier Model 3000). The clinical and laboratory data were used to define four categories of HV infection to distinguish mild HPS with and without hypoxemia or dyspnea ( Table 1) . Absence of radiographic evidence of pulmonary edema was denoted by the new category HV Fever (HF). Mild HPS included two groups: group A, with evidence of pulmonary edema by chest X-ray alone without respiratory symptoms or *n subjects (percent of that category among total with laboratory diagnostic result). †Mild HPS combining both groups A and B (Table 1) , because there were no differences between the two groups.
‡Serum or plasma sample not available for IgM assay. §Sample for PCR degraded from one subject; sample obtained late in illness from another subject.
hypoxemia, and group B, with compatible pulmonary infiltrate, and respiratory insufficiency (respiratory rate 24/min) or hypoxemia by pulse oximetry.
Data were transferred from field collection forms to a database (Microsoft Access 2007) for statistical analyses using Epi-Info Software (version 3.5.3; Centers for Disease Control and Prevention, Atlanta, GA) and TIBCO Spotfire S+ 8.1 for Windows. Differences in clinical characteristics between groups were analyzed by non-parametric tests of proportion (Fisher-Freeman-Halton Exact Test) and Wilcoxon rank sum tests and reported if the difference was significant at P 0.05.
RESULTS
A total of 150 subjects were recruited into the study, including 16 children between the ages of 5 and 15 years ( Table 2 ). The use of both the IgM ELISA and PCR assays identified 117 subjects with presumed HV infection, including 11 of the children recruited (Table 3 ). The IgM assay was positive in 86% (101) of subjects with presumed HV infection. Subjects without pulmonary edema (HF) had less frequent positive IgM (81%) than those subjects with pulmonary edema (91%). Among 16 presumed infections without IgM antibody, 2 infections were not tested for IgM, and 14 infections with positive RT-PCR assays had either HF (10) or mild pulmonary edema without hypoxemia or dyspnea (4). Of 33 subjects with positive IgM and negative PCR, 18 subjects had HF, and 13 subjects had mild HPS; the remaining two subjects with moderate/severe HPS had inadequate samples for PCR test.
IgG immunoblot serology was performed on some acute sera, although lack of follow-up samples prevented documenting seroconversion in the IgG serotype. Of 22 IgG-positives, 19 were IgM-positive; the three negatives presumably represented remote infection and were not counted as HV infection. Among 30 IgM-positive acute sera tested, 19 were IgG-positive, and 11 were IgG-negative, presumably because of early infection.
Six subjects were found to have acute leptospirosis infection, whereas no subjects had malaria, dengue, influenza, rickettsial infection, or infectious mononucleosis (Table 2) . Temporally, 68% of the HV infections detected in these four clinics were diagnosed during the 2007-2008 interval, when HPS diagnoses were elevated above usual levels in the national surveillance system (data not shown).
Symptoms recorded at first clinical presentation did not display dramatic differences between the four categories of HV infection (Table 4) . Weakness, myalgia, and headache were equally common among all HV severity groups, whereas cough (P 0.0003, Fisher-Freeman-Halton Exact Test) and abdominal pain (P 0.002) significantly increased in frequency with increasing severity of illness. Cough was reported in patients with no evidence of pulmonary edema. HV-negative patients had significantly less myalgia (P 0.01) and tended to have less vomiting (P = 0.06), but otherwise, they were clinically indistinguishable from the HV-positive patients.
By definition, all HF patients with recorded chest films (N = 25) had normal X-rays, and all HPS patients had evidence of pulmonary infiltrates consistent with edema (Table 5) . It is important to note that, of 48 radiographed patients with mild HPS, *All subjects had fever. †Myalgia less frequent in non-HV infection (P = 0.01). ‡Cough frequency increasing with severity of HPS (P = 0.0003). §Vomiting tended to be less frequent in non-HV infection (P = 0.06). ¶Abdominal pain increasing with severity of HPS (P = 0.002). kBreath rate and % Sat O 2 : mean [range] (N for data available). *Percent of diagnostic category with chest X-ray finding (N). †Twenty-four (47.1%) patients were ambulatory, and twenty-seven (52.9%) patients were hospitalized.
22 patients (group A) reported no dyspnea or hypoxemia. Among 13 non-HV subjects with chest radiographs, 85% were normal, and only 15% displayed bilateral infiltrates. Among 23 clinical pathology assays, only the platelet counts were significantly lower in HV+ subjects compared with HV− subjects (Table 6 ). HV-infected subjects tended to have lower pO2 tension in arterial blood (67 versus 84) than HV-negative subjects, but serum hepatic enzyme levels and all other assay results were not different (data not shown). Among HVinfected subjects, only the platelet count tended to be decreased with increasing disease severity, but the ranges were broadly overlapping.
DISCUSSION
Sin Nombre infections without pulmonary edema have been described only rarely in North America. 18, 19 The large number of HV infections in this study without pulmonary edema or with mild pulmonary edema in the absence of respiratory insufficiency led us to define two new categories of HV illness. The novel designation HF is intended to be a clinical parallel with dengue fever uncomplicated by pulmonary edema and hemorrhage. The division of mild HPS into two groups is intended to emphasize the frequency of radiographic pulmonary edema in the absence of respiratory insufficiency, and it suggests that HPS is likely underdiagnosed in Panama. The ratio of total HV infections to moderately severe HPS of 9:1 in this study is similar to the ratio of annual seroconversions to hospitalized HPS of 14:1 calculated in these communities. 8 The IgM ELISA and RT-PCR assays were not concordant in all subjects. In hospitalized subjects with HPS in Panama, consistent concordance between the two assays has been shown (Pascale JM, unpublished observations). Some of the negative RT-PCR assays may indicate sample collection after rapid viral clearance in a mild infection. As noted in one Andes virus infection, 20 the absence of IgM-positive assays in the presence of positive PCR assays may represent very early infection. The lack of follow-up samples also prevents unequivocable diagnosis in those subjects without IgG serology performed. Even if only subjects with both assays positive are considered, however, the broad spectrum of clinical HV disease and frequency of mild infection are apparent in Panama.
Recruitment into the study was biased in the sense that clinic personnel focused on infections that were similar to HPS prodrome, including dengue, malaria, and leptospirosis. Febrile illnesses with only upper respiratory symptoms were specifically not recruited, and therefore, HV incidence relative to other viral infections cannot be derived. The high public profile of HV infections in Panama and the accumulated skill in recognizing HPS infection among diagnosticians have enhanced the recognition of infections that mimic HV infection, including leptospirosis. This study suggests, however, that symptoms and laboratory analyses offer minimal distinctions between HV and leptospirosis, requiring specific assays for the latter treatable infection. 21, 22 The lack of consistent thrombocytopenia in mild Choclo virus infection is similar to other clinical mimics, such as dengue, malaria, and leptospirosis, but it is distinct from the almost universal thrombocytopenia found in the more severe Sin Nombre virus infection. 23 The high frequency of HV fever and mild HPS in Choclo virus infection contrasted with the high mortality in Andes virus Table 6 Laboratory findings at first clinic visit for all diagnostic categories infection may reflect the highly specific interaction between HV species and the host integrin receptors. 24 Andes virus is uniformly lethal in hamsters, 25, 26 and viral glycoprotein-integrin interaction is highly specific. 27 However, in hamsters infected with Choclo virus, robust viral replication in the lung is not accompanied by pulmonary inflammation or mortality. 28 Examination of the molecular specificity of this viral protein-integrin interaction may provide clues to the ameliorated pathogenesis in most Choclo virus infections.
Previous antibody prevalence surveys conducted in Panama to identify populations and locations at risk have found sustained increases in incidence of seroconversions compared with hospitalized HPS. 8 Similar seroprevalence rates in Paraguay 9 and Brazil 10-12 may also be consistent with frequent mild disease that does not require hospitalization but may pose a significant economic burden. The identification of all HV infections will improve environmental risk assessments, public health intervention planning, and HV vaccine field evaluations. Increasing seroprevalence in stable populations 8 suggests an increasing incidence of HV infections in Panama. The changing agroeconomy in Panama emphasizing rice monoculture, with increased rodent food supply and reduced rodent diversity, 29, 30 may be increasing the risk of human HV infection.
